President, Chief Executive Officer
Thomas King has served as President, Chief Executive Officer and a member of the Board since June 2003. From September 2002 to April 2003, Mr King served as President, Chief Executive Officer and a member of the board of directors of Cognetix, Inc., a biopharmaceutical development company.
From January 1994 to February 2001, Mr King held various senior executive positions, at Anesta Corporation, a publicly traded pharmaceutical company, including President and Chief Executive Officer from January 1997 to October 2000, and was a member of the board of directors until it was acquired by Cephalon, a publicly traded biopharmaceutical company. Mr King received an MBA from the University of Kansas and a BA in chemistry from McPherson College.